F-star Therapeutics, Inc.
F-star Therapeutics, Inc.（FSTX）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · FSTX · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
F-star Therapeutics, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
FSTX 季度内部人买卖趋势
FSTX 内幕交易卖出 · FSTX 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
近期内幕交易记录
FSTX 高管卖出股份 · FSTX 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Mar 8, 2023 | Kayitalire Louis CHIEF MEDICAL OFFICER | Other | 29,236 | $208K | Form 4 |
| Mar 8, 2023 | Kayitalire Louis CHIEF MEDICAL OFFICER | Other | 25,019 | $178K | Form 4 |
| Mar 8, 2023 | Forster Eliot PRESIDENT AND CEO · Director | Other | 347,578 | $2.47M⚡ | Form 4 |
| Mar 8, 2023 | Forster Eliot PRESIDENT AND CEO · Director | Other | 73,959 | $527K | Form 4 |
| Mar 8, 2023 | DEPTULA-HICKS DARLENE M See Remarks | Other | 30,898 | $220K | Form 4 |
| Mar 8, 2023 | DEPTULA-HICKS DARLENE M See Remarks | Other | 25,539 | $182K | Form 4 |
| Mar 8, 2023 | Brady Todd C Director | Other | 15,004 | $107K | Form 4 |
| Mar 8, 2023 | Brewis Neil CHIEF SCIENTIFIC OFFICER | Other | 105,088 | $748K | Form 4 |
| Mar 8, 2023 | Brewis Neil CHIEF SCIENTIFIC OFFICER | Other | 9,375 | $67K | Form 4 |
| Mar 8, 2023 | Race Geoffrey Director | Other | 3,937 | $28K | Form 4 |
| Mar 8, 2023 | Bermingham Nessan Director | Other | 97,547 | $695K | Form 4 |
| Mar 8, 2023 | Bermingham Nessan Director | Other | 6,328 | $45K | Form 4 |
| Mar 8, 2023 | Benz Edward JR Director | Other | 4,385 | $31K | Form 4 |
| Mar 8, 2023 | Arkowitz David Director | Other | 8,386 | $60K | Form 4 |
| Jul 29, 2022 | Brewis Neil Chief Scientific Officer | Option | 76,619 | $8K | Form 4 |
| Nov 2, 2021 | Kayitalire Louis Chief Medical Officer | Sale | 39 | $266 | Form 4 |
| Nov 2, 2021 | Kayitalire Louis Chief Medical Officer | Sale | 25 | $171 | Form 4 |
| Oct 4, 2021 | Kayitalire Louis Chief Medical Officer | Sale | 64 | $462 | Form 4 |
| Jul 2, 2021 | Kayitalire Louis Chief Medical Officer | Sale | 1,054 | $9K | Form 4 |
Forster Eliot
PRESIDENT AND CEO · Director
日期
Mar 8
股数
347,578
均价
$7.12
总金额
$2.47M ⚡
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 FSTX 内幕交易
FSTX 内幕交易
F-star Therapeutics, Inc.（FSTX）内幕交易数据来源于公司内部人（包括FSTX）提交的SEC Form 4申报文件。过去12个月内，0位内部人向SEC提交了交易申报。FSTX内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看F-star Therapeutics, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
FSTX 内幕交易 · 5个问题F-star Therapeutics, Inc.（FSTX）的内部人包括高管和董事，如FSTX等。过去12个月内，0位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026